Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia.
Hirashima
K
K
First Department of Internal Medicine, Saitama Medical School, Japan.
Bessho
M
M
Jinnai
I
I
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000188:drug therapy*; D000741:Anemia, Aplastic / Q000188:drug therapy*; D001803:Blood Transfusion; D004909:Erythrocyte Indices / Q000187:drug effects; D015672:Erythroid Precursor Cells / Q000187:drug effects; D004921:Erythropoietin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin